New approaches to genetic manipulation of mice: Tissue-specific expression of ACE

American Journal of Physiology - Renal Physiology

Volumn 284, Issue 4 53-4, 2003, Pages

  Cole, Justin M ^a   Xiao, Hong ^a   Adams, Jonathan W ^a   Disher, Kevin M ^a   Zhao, Hui ^a   Bernstein, Kenneth E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Angiotensin converting enzyme; Blood pressure; Liver; Renin angiotensin system

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL CELL; ANIMAL TISSUE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; ELECTROLYTE BLOOD LEVEL; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ERYTHROPOIESIS; GENE INACTIVATION; GENE TARGETING; GENETIC MANIPULATION; KIDNEY DEVELOPMENT; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; NULL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TISSUE SPECIFICITY;

EID: 0037377229     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00308.2002     Document Type: Review

References (58)

1. American Heart Association. Heart and Stroke Statistical Update, AHA, 2002, p. 4.
2. Beldent V, Michaud A, Wei L, Chauvet MT, and Corvol P. Proteolytic release of human angiotensin-converting enzyme: localization of the cleavage site. J Biol Chem 268: 26428-26434, 1993.
3. Bernstein KE, Martin BM, Edwards AS, and Bernstein EA. Mouse angiotensin I-converting enzyme is a protein composed of two homologous domains. JBiol Chem 264: 11945-11951, 1989.
4. Capecchi MR. Targeted gene replacement. Scientific American 270: 52-59, 1994.
5. Chai SY, Mendelsohn FAO, and Paxinos G. Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography. Neuroscience 20: 615-627, 1987.
6. Chen X, Li W, Yoshida H, Tsuchida S, Nishimura H, Takemoto F, Okubo S, Fogo A, Matsusaka T, and Ichikawa I. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol Renal Physiol 272: F299-F304, 1997.
7. Clark AF, Sharp MF, Morley SD, Fleming S, Peters J, and Mullins JJ. Renin-1 is essential for normal renal juxtaglomerular cell granulation and macula densa morphology. J Biol Chem 272: 18185-18190, 1997.
8. Cole J, Ertoy D, Lin H, Sutliff RL, Ezan E, Guyene TT, Capecchi M, Corvol P, and Bernstein KE. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensinconverting enzyme deficient mice. J Clin Invest 106: 1391-1398, 2000.
9. Cole J, Quach DL, Sundaram K, Corvol P, Capecchi MR, and Bernstein KE. Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure. Circ Res 90: 87-92, 2002.
10. Cushman DW and Cheung HS. Concentration of the angiotensin-converting enzyme in tissues of rat. Biochimica et Biophysica Acta 250: 261-265, 1971.
11. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, and Dzau VJ. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94: 2756-2767, 1996.
12. Ding Y, Davisson RL, Hardy DO, Zhu LJ, Merrill DC, Catterall JF, and Sigmund CD. The kidney androgen-regulated protein promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angio- tensinogen gene in transgenic mice. J Biol Chem 272: 28142-28148, 1997.
13. Ding Y, Stec DE, and Sigmund CD. Genetic evidence that lethality in angiotensinogen-deficient mice is due to loss of systemic but not renal angiotensinogen. J Biol Chem 276: 7431-7436, 2001.
14. Dzau VJ. Tissue angiotensin and pathobiology of vascular disease. Hypertens 37: 1047-1052, 2001.
15. Ehlers MR, Fox EA, Strydom DJ, and Riordan JF. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci USA 86: 7741-7745, 1989.
16. Ertürk S, Nergizoglu G, Ates K, Duman N, Erbay B, Karatan O, and Ertug AE. The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients. Nephrol Dial Transplant 14: 1912-1916, 1999.
17. Esther CR Jr, Howard TE, Marino EM, Goddard JM, Capecchi MR, and Bernstein KE. Mice lacking angiotensinconverting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74: 953-965, 1996.
18. Esther CR, Marino EM, Howard TE, Corvol P, Capecchi MR, and Bernstein KE. The critical role of the tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 99: 2375-2385, 1997.
19. Glicklich D, Burris L, Urban A, Tellis V, Greenstein S, Schechner R, Devarajan P, and Croizat H. Angiotensinconverting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis. J Am Soc Nephrol 12: 1958-1964, 2001.
20. Hein L, Barsh GS, Pratt RE, Dzau VJ, and Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 377: 744-747, 1995.
21. th intron of the somatic ACE gene. Mol Cell Biol 10: 4294-4302, 1990.
22. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, and Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377: 748-750, 1995.
23. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, and Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 92: 3521-3525, 1995.
24. Kieran MW, Perkins AC, Orkin SH, and Zon LI. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc Natl Acad Sci USA 93: 9126-9131, 1996.
25. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, and Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 92: 2735-2739, 1995.
26. Klein JD, Quach DL, Cole JM, Disher K, Mongiu AK, Wang X, Bernstein KE, and Sands JM. Impaired urine concentration and absence of tissue ACE: involvement of medullary transport proteins. Am J Physiol Renal Physiol 283: F517-F524, 2002.
27. Krege JH, John SWM, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, and Smithies O. Male-female differences in fertility and blood pressure in ACE deficient mice. Nature 375: 146-148, 1995.
28. Krege JH, Kim HS, Moyer JS, Jennette JC, Peng L, Hiller SK, and Smithies O. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 29: 150-157, 1997.
29. Kumar RS, Kusari J, Roy SN, Soffer RL, and Sen GC. Structure of testicular angiotensin converting enzyme: a segmental mosaic isozyme. J Biol Chem 264: 16754-16758, 1989.
30. Lattion AL, Soubrier F, Allegrinin J, Hubert C, Corvol P, and Alhenc-Gelas F. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, nonduplicated form of the enzyme. FEBS Lett 252: 99-104, 1989.
31. Lewandoski M. Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743-755, 2001.
32. Lin CS, Lim SK, D'Agati V, and Costantini F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev 10: 154-164, 1996.
33. Macdougall IC. The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin. Nephrol Dial Transplant 14: 1836-1841, 1999.
34. 1 receptor. Nature 375: 247-250, 1995.
35. Matsumura Y, Uchida S, Kondo Y, Miyazaki H, Ko SB, Hayama A, Morimoto T, Liu W, Arisawa M, Sasaki S, and Marumo F. Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nat Genet 21: 95-98, 1999.
36. Matsusaka T, Kon V, Takaya J, Katori H, Chen X, Miyazaki J, Homma T, Fogo A, and Ichikawa I. Dual renin gene targeting by Cre-mediated interchromosomal recombination. Genomics 64: 127-131, 2000.
37. Matsusaka T, Nishimura H, Utsunomiya H, Kakuchi J, Nimura F, Inagami T, Fogo A, and Ichikawa I. Chimeric mice carrying "regional" targeted deletion of the angiotensin type 1A receptor gene. J Clin Invest 98: 1867-1187, 1996.
38. Meseguer A and Catterall JF. Mouse kidney androgen-regulated protein messenger ribonucleic acid is expressed in the proximal convoluted tubules. Mol Endocrinol 1: 535-541, 1987.
39. Miyazaki Y, Tsuchida S, Fogo A, and Ichikawa I. The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy. Kidney Int 55: 1683-1695, 1999.
40. Miyazaki Y, Tsuchida S, Nishimura H, Pope JC, Harris RC, McKanna JM, Inagami T, Hogan BLM, Fogo A, and Ichikawa I. Angiotensin induces urinary peristaltic machinery during the perinatal period. J Clin Invest 102: 1489-1497, 1998.
41. Müller DN, Bohlender J, Hilgers KF, Dragun D, Costerousse O, Menard J, and Luft FC. Vascular angiotensin-converting enzyme expression regulates local angiotensin II. Hypertens. 29: 98-104, 1997.
42. Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, and Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93: 397-409, 1998.
43. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, Ichiki T, Naftilan AJ, Fogo A, Inagami T, and Ichikawa I. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth regulation. J Clin Invest 96: 2947-2954, 1995.
44. 1B receptors for angiotensin II. Proc Natl Acad Sci USA 95: 15496-15501, 1998.
45. Pinkert CA, Ornitz DM, Brinster RL, and Palmiter RD. An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Develop 1: 268-276, 1987.
46. Ramaraj P, Kessler SP, Colmenares C, and Sen GC. Selective restoration of male fertility in mice lacking angiotensinconverting enzymes by sperm-specific expression of the testicular isozyme. J Clin Invest 102: 371-378, 1998.
47. Runic R, Zhu LJ, Crozat A, Bagchi MK, Catterall JF, and Bagchi IC. Estrogen regulates the stage-specific expression of kidney androgen-regulated protein in rat uterus during reproductive cycle and pregnancy. Endocrinol 137: 729-737, 1996.
48. Sharp MG, Fettes D, Brooker G, Clark AF, Peters J, Fleming S, and Mullins JJ. Targeted inactivation of the Ren-2 gene in mice. Hypertension 28: 1126-1131, 1996.
49. Sibony M, Gasc JM, Soubrier F, Alhenc-Gelas F, and Corvol P. Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension 21: 827-835, 1993.
50. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrinin J, John M, Tregar G, and Corvol P. Two putative active centers in human angiotensin-I converting enzyme revealed by molecular cloning. Proc Natl Acac Sci USA 85: 9386-9390, 1988.
51. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, Uchida H, Sugiura M, Fukuta K, Fukamizu A, and Murakami K. Angiotensin II type 1a receptor deficient mice with hypotension and hyperreninemia. J Biol Chem 270: 18719-18722, 1995.
52. Takada Y, Hiwada K, Akutsu H, Hashimoto A, and Kokubu T. The immunocytochemical detection of angiotensin-converting enzyme in alveolar macrophages from patients with sarcoidosis. Lung 162: 317-323, 1984.
53. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, and Murakami K. Angiotensinogendeficient mice with hypotension. J Biol Chem 269: 31334-31337, 1994.
54. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Fogo A, Utsunomiya H, Inagami T, and Ichikawa I. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 101: 755-760, 1998.
55. Vlahakos DV, Kosmas EN, Dimopoulou I, Ikonomou E, Jullien G, Vassilakos P, and Marathias KP. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. Am J Med 106: 158-164, 1999.
56. Wei L, Alhenc-Gelas F, Corvol P, and Clauser E. The two catalytic domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem 266: 9002-9008, 1991.
57. Wu H, Liu X, Jaenisch R, and Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83: 59-67, 1995.
58. Yanai K, Saito T, Kakinuma Y, Kon Y, Hirota K, Taniguchi-Yanai K, Nishijo N, Shigematsu Y, Horiguchi H, Kasuya Y, Sugiyama F, Yagami K, Murakami K, and Fukamizu A. Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renindeficient mice. J Biol Chem 275: 5-8, 2000.